Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats

Cardiovascular Drugs and Therapy

Volumn 18, Issue 6, 2004, Pages 461-468

  Omar, Amal G ^a   El Mas, Mahmoud M ^a,b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Autonomic blockade; Blood pressure; Cyclosporine; Heart rate; Hemodynamic variability; Time domain analysis

Indexed keywords

ATROPINE; CYCLOSPORIN; CYCLOSPORIN A; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CONTROLLED STUDY; DRUG ACTIVITY; HEART BEAT; HEART HEMODYNAMICS; HEART RATE VARIABILITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT; RR INTERVAL; STANDARD; TACHYCARDIA; VAGUS NERVE;

ANIMALS; ATROPINE; BLOOD PRESSURE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; HEART RATE; HEMODYNAMIC PROCESSES; MALE; PROPRANOLOL; RATS; RATS, WISTAR; TIME FACTORS;

EID: 16844383241     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-004-6223-1     Document Type: Article

References (47)

1. Ori Z, Monir G, Weiss J, Sayhouni X, Singer DH. Heart rate variability: Frequency domain analysis. In: Kennedy HL, ed. Cardiology Clinics, Vol. 10, No. 3. Philadelphia: W.B. Saunders Co., 1992:499-533.
2. Japundzic-Zigon N. Physiological mechanisms in regulation of blood pressure fast frequency variations. Clin Exp Hypertens 1998;20:359-388.
3. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. Am Heart J 1994;127:1376-1381.
4. Huikuri HV, Jokinen V, Sy vanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979-1985.
5. Zipes DP, Miyazaki T. The autonomic nervous system and the heart: Basis for understanding interactions and effects on arrhythmia development. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside. Philadelphia, PA: Saunders, 1990:312-330.
6. Sgoifo A, de Boer SF, Westenbroek C, et al. Incidence of arrhythmias and heart rate variability in wild-type rats exposed to social stress. Am J Physiol 1997;273:H1754-1760.
7. Friedwald, VE, Spence DW. Sudden death associated with exercise: The risk-benefit issue. Am J Cardiol 1990;66:183-188.
8. Billman GE. Aerobic exercise conditioning: A nonpharmacological antiarrhythmic intervention. J Appl Physiol 2002;92:446-454.
9. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000;36:894-900.
10. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens 1995;13(suppl 4):S27-S34.
11. Chaouche-Teyara K, Lacolley P, Challande P, et al. Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 1997;30:241-244.
12. Timio M, Venanzi S, Gentili S, Ronconi M, Del Re G, Del Vita M. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: Relationship between echocardiographic findings, blood pressure, and urinary catecholamines. J Cardiovasc Pharmacol 1987;10 (Suppl 12):S142-S146.
13. Kovarik JM, Burtin P. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin Emerg Drugs 2003;8:47-62.
14. Mason J. Pharmacology of cyclosporine (Sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 1990;41:423-434.
15. Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: Glomerular thromboses and tubular injury. N Engl J Med 1981;305:1392-1395.
16. LoVecchio FA, Goltz HR. Atrial fibrillation following acute overdose with oral cyclosporine. Ann Pharmacother 2000;34:405.
17. Semeniuk LM, Severson DL, Kryski AJ, Swirp SL, Molkentin JD, Duff HJ. Time-dependent systolic and diastolic function in mice overexpressing calcineurin. Am J Physiol Heart Circ Physiol 2003;284:H425-H430.
18. Ko WJ, Lin FL, Wang SS, Chu SH. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. J Heart Lung Transplant 1997;16:980-982.
19. Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl 2002;8:690-700.
20. Roberts CA, Stern DL, Radio SJ. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation 2002;74:817-821.
21. Banijamali HS, ter Keurs MH, Paul LC, ter Keurs HE. Excitation- contraction coupling in rat heart: Influence of cyclosporin A. Cardiovasc Res 1993;27:1845-1854.
22. Wickenden AD, Kaprielian R, Kassiri Z, et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 1998;37:312-323.
23. Gerhardt LT, Riedasch M, Hohage H. Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 1999;68:203-208.
24. El-Mas MM, Afify EA, Omar AG, Sharabi FM. Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Ther 2002;301:346-354.
25. El-Mas MM, Afify EA, Omar AG, Sharabi FM. Cyclosporine attenuates the autonomic modulation of reflex chronotropic responses in conscious rats. Can J Physiol Pharmacol 2002;80:766-776.
26. El-Mas MM, Abdel-Rahman AA. Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats. J Pharmacol Exp Ther 1992;262:157-165.
27. El-Mas MM, Abdel-Rahman AA. Contrasting effects of urethane, ketamine, and thiopental anesthesia on ethanol-clonidine hemodynamic interaction. Alcohol Exp Clin Res 1997;21:19-27.
28. El-Mas MM. Facilitation of reflex bradycardia does not contribute to the enhanced hypotensive effect of clonidine in aortic barodenervated rats. J Cardiovasc Pharmacol 1998;31:869-875.
29. Coleman TG. Arterial baroreflex control of heart rate in the conscious rat. Am J Physiol 1980;238:H515-H520.
30. El-Mas MM, Afify EA, Mohy El-Din MM, Omar AG, Sharabi FM. Testosterone facilitates the baroreceptor control of reflex bradycardia: Role of cardiac sympathetic and parasympathetic components. J Cardiovasc Pharmacol 2001;38:754-763.
31. El-Mas MM, Abdel-Rahman AA. Effects of chronic ethanol feeding on clonidine-evoked reductions in blood pressure, heart rate, and their variability: Time-domain analyses. J Pharmacol Exp Ther 2003;306:271-278.
32. El-Mas MM, Abdel-Rahman AA. Effects of long-term ovariectomy and estrogen replacement on clonidine-evoked reductions in blood pressure and hemodynamic variability. J Cardiovasc Pharmacol 2004;43:607-615.
33. El-Mas MM, Abdel-Rahman AA. Radiotelemetric evaluation of the hemodynamic effects of long-term ethanol in spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther 2000;292:944-951.
34. Visser EK, van Reenen CG, van der Werf JT, et al. Heart rate and heart rate variability during a novel object test and a handling test in young horses. Physiol Behav 2002;76:289-296.
35. Ryuzaki M, Stahl LK, Lyson T, Victor RG, Bishop VS. Sympathoexcitatory response to cyclosporin A and baroreflex resetting. Hypertension 1997;29:576-582.
36. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985;82:8222-8226.
37. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after transplantation. N Engl J Med 1990;323:693-699.
38. Xue H, Bukoski RD, McCarron DA, Bennett MW. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 1987;43:715-718.
39. Gerkens JF. Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators. J Pharmacol Exp Ther 1989;250:1105-1112.
40. Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis 1994;23:471-475.
41. Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 2000;13:999-1004.
42. Zhang W, Li JL, Hosaka M, et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci USA 2000;97:9765-9770.
43. Marcaida G, Kosenko E, Minana MD, Grisolia S, Felipo V. Glutamate induces a calcineurin-mediated dephosphorylation of Na+,K(+)-ATPase that results in its activation in cerebellar neurons in culture. J Neurochem 1996;66:99-104.
44. Kumada M, Terui N, Kuwaki T. Arterial baroreceptor reflex: Its central and peripheral neural mechanisms. Prog Neurobiol 1990;35:331-361.
45. + channels in cardiac sensory afferent neurons. Brain Res 1998;786:243-247.
46. Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: Unique insights into cardiovascular regulation. Am J Physiol 1991;261:H1231-H1245.
47. Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: Effects of autonomic blockers. J Auton Nerv Syst 1990;30:91-100.